Assignee
KYMERA THERAPEUTICS INC
US·43 granted patents·66 pending applications·293 citations·filing 2018–2025
Top patents by PatentIndex Score
109 records- 0198US11746120B2Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Sep 5, 2023·12 cites·30 claims
- 0298US11723980B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Aug 15, 2023·9 cites·14 claims
- 0398US11485750B1STAT degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Nov 1, 2022·7 cites·20 claims
- 0498US11117889B1IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Sep 14, 2021·28 cites·28 claims
- 0598US10874743B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Dec 29, 2020·38 cites·20 claims
- 0697US12258341B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Mar 25, 2025·5 cites·18 claims
- 0797US12168057B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Dec 17, 2024·5 cites·17 claims
- 0897US12077555B2STAT degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Sep 3, 2024·3 cites·14 claims
- 0997US11807636B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·6 cites·19 claims
- 1097US11707457B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Jul 25, 2023·11 cites·30 claims
- 1197US11292792B2Tricyclic CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Apr 5, 2022·19 cites·15 claims
- 1296US12006329B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Jun 11, 2024·4 cites·9 claims
- 1396US11779578B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Oct 10, 2023·7 cites·20 claims
- 1496US11591332B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Feb 28, 2023·9 cites·19 claims
- 1596US11512080B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Nov 29, 2022·15 cites·20 claims
- 1696US11358948B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Jun 14, 2022·16 cites·16 claims
- 1796US11352350B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Jun 7, 2022·20 cites·11 claims
- 1895US12091411B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·5 cites·9 claims
- 1995US11857535B2Methods of treating mutant lymphomasKYMERA THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·6 cites·30 claims
- 2095US11318205B1IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted May 3, 2022·10 cites·14 claims
- 2194US12150995B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·4 cites·15 claims
- 2294US11932624B2MDM2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Mar 19, 2024·2 cites·30 claims
- 2393US12516068B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Granted Jan 6, 2026·1 cites·7 claims
- 2493US12171768B2IRAK4 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Dec 24, 2024·6 cites·4 claims
- 2592US11932635B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Mar 19, 2024·1 cites·21 claims
- 2691US11897882B2Tricyclic crbn ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Feb 13, 2024·1 cites·19 claims
- 2791US11685750B2Crystalline forms of IRAK degradersKYMERA THERAPEUTICS INC·Filed 2021·Granted Jun 27, 2023·13 cites·29 claims
- 2890US12187744B2IRAK4 degraders and synthesis thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Jan 7, 2025·6 cites·18 claims
- 2990US11679109B2SMARCA degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Jun 20, 2023·3 cites·16 claims
- 3090US11623932B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Apr 11, 2023·3 cites·13 claims
- 3189US11485743B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Nov 1, 2022·6 cites·8 claims
- 3287US11773103B2IRAK4 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Oct 3, 2023·11 cites·25 claims
- 3387US2025000985A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3485US2025059221A1Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3583US2026085075A1Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3681US2025051320A1Crbn ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3780US2025042902A1Tricyclic crbn ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3879US12539295B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Feb 3, 2026·0 cites·20 claims
- 3977US2026042749A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4076US12097261B2CDK2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Sep 24, 2024·0 cites·12 claims
- 4176US2025011325A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4275US12454520B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Oct 28, 2025·1 cites·16 claims
- 4375US2025214977A1Stat6 inhibitors and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4475US2025121073A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4575US2025325673A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4675US2023234953A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4775US2025114461A1Cdk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4874US2025163042A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4974US2025333417A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 5073US2025388566A1Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 109 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when KYMERA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →